Follow
Wolfgang Bethge
Wolfgang Bethge
Medical Center University Hospital of Tuebingen
Verified email at med.uni-tuebingen.de
Title
Cited by
Cited by
Year
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open …
J Finke, WA Bethge, C Schmoor, HD Ottinger, M Stelljes, AR Zander, ...
The lancet oncology 10 (9), 855-864, 2009
7832009
International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium
AC Harris, R Young, S Devine, WJ Hogan, F Ayuk, U Bunworasate, ...
Biology of Blood and Marrow Transplantation 22 (1), 4-10, 2016
6132016
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell …
T Feuchtinger, K Opherk, WA Bethge, MS Topp, FR Schuster, ...
Blood, The Journal of the American Society of Hematology 116 (20), 4360-4367, 2010
5312010
Antilymphocyte globulin for prevention of chronic graft-versus-host disease
N Kröger, C Solano, C Wolschke, G Bandini, F Patriarca, M Pini, A Nagler, ...
New England Journal of Medicine 374 (1), 43-53, 2016
5192016
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party …
N Kröger, E Holler, G Kobbe, M Bornhäuser, R Schwerdtfeger, ...
Blood, The Journal of the American Society of Hematology 114 (26), 5264-5270, 2009
4612009
Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation …
A Burchert, G Bug, LV Fritz, J Finke, M Stelljes, C Röllig, E Wollmer, ...
Journal of Clinical Oncology 38 (26), 2993-3002, 2020
3872020
Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies
ML Sorror, BM Sandmaier, BE Storer, GN Franke, GG Laport, ...
Jama 306 (17), 1874-1883, 2011
3322011
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius
G Socié, C Schmoor, WA Bethge, HD Ottinger, M Stelljes, AR Zander, ...
Blood, The Journal of the American Society of Hematology 117 (23), 6375-6382, 2011
3272011
Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell …
V Icheva, S Kayser, D Wolff, S Tuve, C Kyzirakos, W Bethge, J Greil, ...
J Clin Oncol 31 (1), 39-48, 2013
2972013
Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation
R Storb, B Gyurkocza, BE Storer, ML Sorror, K Blume, D Niederwieser, ...
Journal of Clinical Oncology 31 (12), 1530, 2013
2582013
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
NR Mathew, F Baumgartner, L Braun, D O'Sullivan, S Thomas, ...
Nature medicine 24 (3), 282-291, 2018
2502018
Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia
H Pfeifer, B Wassmann, W Bethge, J Dengler, M Bornhäuser, M Stadler, ...
Leukemia 27 (6), 1254-1262, 2013
2502013
Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia
B Gyurkocza, R Storb, BE Storer, TR Chauncey, T Lange, JA Shizuru, ...
Journal of clinical oncology 28 (17), 2859, 2010
2482010
Dose-reduced versus standard conditioning followed by allogeneic stem-cell transplantation for patients with myelodysplastic syndrome: a prospective randomized phase III study …
N Kroger, S Iacobelli, G Franke, U Platzbecker, R Uddin, K Hubel, ...
Journal of Clinical Oncology 35 (19), 2157-2164, 2017
2252017
CAR-HEMATOTOX: a model for CAR T-cell–related hematologic toxicity in relapsed/refractory large B-cell lymphoma
K Rejeski, A Perez, P Sesques, E Hoster, C Berger, L Jentzsch, ...
Blood, The Journal of the American Society of Hematology 138 (24), 2499-2513, 2021
2062021
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
C Kahl, BE Storer, BM Sandmaier, M Mielcarek, MB Maris, KG Blume, ...
Blood, The Journal of the American Society of Hematology 110 (7), 2744-2748, 2007
1822007
Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change
M Christopeit, O Kuss, J Finke, U Bacher, DW Beelen, M Bornhäuser, ...
Journal of clinical oncology 31 (26), 3259-3271, 2013
1772013
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update
WA Bethge, C Faul, M Bornhäuser, G Stuhler, DW Beelen, P Lang, ...
Blood Cells, Molecules, and Diseases 40 (1), 13-19, 2008
1762008
Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders
GG Laport, BM Sandmaier, BE Storer, BL Scott, MJ Stuart, T Lange, ...
Biology of Blood and Marrow Transplantation 14 (2), 246-255, 2008
1642008
Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning
WA Bethge, U Hegenbart, MJ Stuart, BE Storer, MB Maris, MED Flowers, ...
Blood 103 (3), 790-795, 2004
1592004
The system can't perform the operation now. Try again later.
Articles 1–20